Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Data Bridge Market Research | PRODUCT CODE: 1393416

Cover Image

PUBLISHER: Data Bridge Market Research | PRODUCT CODE: 1393416

Asia-Pacific Chinese Hamster Ovary (CHO) Cells Market - Industry Trends and Forecast to 2030

PUBLISHED:
PAGES: 183 Pages
DELIVERY TIME: Inquiry
SELECT AN OPTION
PDF (Single User License) - Printable/Downloadable
USD 3500
PDF (Enterprise License) - Printable/Downloadable
USD 4200

Add to Cart

Asia-Pacific Chinese hamster ovary (CHO) cells market is projected to register a CAGR of 9.9% in the forecast period of 2023 to 2030. The new market report contains data for the historic year 2021, the base year of calculation is 2022 and the forecast period is 2023 to 2030.

Market Segmentation

Asia-Pacific Chinese Hamster Ovary (CHO) Cells Market, Type (Services and Product), System (Metabolic Selection System, Antibiotic Selection System, and Others), Application (Biologics and Medical Research), End-user (Biopharmaceutical Companies, Biotechnology Companies, Clinical Development and Manufacturing Organizations, Clinical Research Organizations, Academic Institutes and Research Organizations, and Others), Distribution Channel (Direct Tenders, Retail Sales and Others), Country (China, Japan, India, Australia, South Korea, New Zealand, Singapore, Thailand, Philippines, Malaysia, Indonesia, Vietnam, Taiwan, and Rest of Asia-Pacific) - Industry Trends and Forecast to 2030.

Overview of Asia-Pacific Chinese Hamster Ovary (CHO) Cells Market Dynamics

  • Driver
  • Rising use of CHO cells in the genetic study
  • Restraint
  • High cost of CHO cell-based production
  • Opportunity
  • Continuous development of cell culture technologies

Market Players

Some major companies dealing in the Asia-Pacific Chinese hamster ovary (CHO) cells market are:

  • Thermo Fisher Scientific Inc. (U.S.)
  • AcceGen (U.S.)
  • RayBiotech Life, Inc. (U.S.)
  • CLS Cell Lines Service GmbH (Germany)
  • BPS Bioscience, Inc. (U.S.)
  • GenTarget Inc. (U.S.)
  • Merck KGaA (Germany)
  • Promega Corporation (U.S.)
  • Abeomics (U.S.)
  • Applied Biological Materials Inc. (abm) (Canada)
  • ATCC (U.S.)
  • Sartorius AG (Germany)
  • Lonza (Switzerland)
  • Horizon Discovery Ltd. (U.K.)
  • Cytiva (U.S.)
  • Curia global, Inc. (U.S.)

TABLE OF CONTENTS

1 INTRODUCTION 22

  • 1.1 OBJECTIVES OF THE STUDY 22
  • 1.2 MARKET DEFINITION 22
  • 1.3 OVERVIEW OF THE ASIA-PACIFIC CHINESE HAMSTER OVARY CELLS (CHO) MARKET 22
  • 1.4 LIMITATIONS 24
  • 1.5 MARKETS COVERED 24

2 MARKET SEGMENTATION 26

  • 2.1 MARKETS COVERED 26
  • 2.2 GEOGRAPHICAL SCOPE 27
  • 2.3 YEARS CONSIDERED FOR THE STUDY 27
  • 2.4 CURRENCY AND PRICING 27
  • 2.5 DBMR TRIPOD DATA VALIDATION MODEL 28
  • 2.6 MULTIVARIATE MODELLING 31
  • 2.7 BY TYPE LIFELINE CURVE 31
  • 2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 32
  • 2.9 DBMR MARKET POSITION GRID 33
  • 2.10 MARKET APPLICATION COVERAGE GRID 34
  • 2.11 VENDOR SHARE ANALYSIS 35
  • 2.12 SECONDARY SOURCES 36
  • 2.13 ASSUMPTIONS 36

3 EXECUTIVE SUMMARY 37

4 PREMIUM INSIGHTS 40

  • 4.1 PESTEL ANALYSIS 41
  • 4.2 PORTER'S FIVE FORCES 42

5 ASIA-PACIFIC CHINESE HAMSTER OVARY CELLS (CHO) MARKET, REGULATIONS 43

6 MARKET OVERVIEW 45

  • 6.1 DRIVERS 47
    • 6.1.1 RISING USE OF CHO CELLS IN THE GENETIC STUDY 47
    • 6.1.2 GROWING DEMAND FOR BIOPHARMACEUTICALS 48
    • 6.1.3 RISING INVESTMENTS IN BIOTECHNOLOGY R&D 48
    • 6.1.4 RISING DEMAND FOR MONOCLONAL ANTIBODIES 50
  • 6.2 RESTRAINTS 51
    • 6.2.1 HIGH-COST OF CHO CELL-BASED PRODUCTION 51
    • 6.2.2 STRICT REGULATORY REQUIREMENTS FOR CHO CELL-BASED PRODUCTION 52
  • 6.3 OPPORTUNITIES 53
    • 6.3.1 CONTINUOUS DEVELOPMENT OF CELL CULTURE TECHNOLOGIES 53
    • 6.3.2 RISING NUMBER OF APPLICATIONS OF CHO CELLS 54
  • 6.4 CHALLENGES 55
    • 6.4.1 TIME-CONSUMING AND INCONSISTENCY IN THE CHO CELL LINE DEVELOPMENT PROCESS 55
    • 6.4.2 CONTAMINATION RISK OF CHO CELL CULTURES 56

7 ASIA-PACIFIC CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE 58

  • 7.1 OVERVIEW 59
  • 7.2 SERVICES 62
  • 7.3 PRODUCT 62
    • 7.3.1 CHO-DXB11 62
    • 7.3.2 CHO-K1 63
      • 7.3.2.1 CHO-K1 ATCC 63
      • 7.3.2.2 CHO-K1 ECACC 63
      • 7.3.2.3 OTHERS 63
    • 7.3.3 CHO-DG44 63
    • 7.3.4 CHO-S 63
    • 7.3.5 OTHERS 63

8 ASIA-PACIFIC CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY SYSTEM 64

  • 8.1 OVERVIEW 65
  • 8.2 METABOLIC SELECTION SYSTEM 68
  • 8.3 ANTIBIOTIC SELECTION SYSTEM 68
  • 8.4 OTHERS 68

9 ASIA-PACIFIC CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION 69

  • 9.1 OVERVIEW 70
  • 9.2 BIOLOGICS 73
    • 9.2.1 MONOCLONAL ANTIBODIES 73
    • 9.2.2 ENZYMES 73
    • 9.2.3 CYTOKINES 73
    • 9.2.4 CLOTTING FACTORS 73
    • 9.2.5 HORMONES 74
    • 9.2.6 FC-FUSION PROTIEN 74
    • 9.2.7 OTHERS 74
  • 9.3 MEDICAL RESEARCH 74 

10 ASIA-PACIFIC CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY END USER 75

  • 10.1 OVERVIEW 76
  • 10.2 BIOPHARMACEUTICAL COMPANIES 79
    • 10.2.1 MEDIUM 79
    • 10.2.2 SMALL 79
  • 10.3 BIOTECHNOLOGY COMPANIES 79
    • 10.3.1 MEDIUM 80
    • 10.3.2 SMALL 80
  • 10.4 CLINICAL DEVELOPMENT AND MANUFACTURING ORGANIZATIONS 80
    • 10.4.1 MEDIUM 80
    • 10.4.2 SMALL 80
  • 10.5 CLINICAL RESEARCH ORGANIZATIONS 81
    • 10.5.1 MEDIUM 81
    • 10.5.2 SMALL 81
  • 10.6 ACADEMIC INSTITUTES AND RESEARCH ORGANIZATIONS 81
  • 10.7 OTHERS 81

11 ASIA-PACIFIC CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY DISTRIBUTION CHANNEL 82

  • 11.1 OVERVIEW 83
  • 11.2 DIRECT TENDERS 86
  • 11.3 RETAIL SALES 86
  • 11.4 OTHERS 86

12 ASIA-PACIFIC CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY COUNTRY 87

  • 12.1 ASIA-PACIFIC 87
    • 12.1.1 CHINA 90
    • 12.1.2 JAPAN 95
    • 12.1.3 INDIA 100
    • 12.1.4 AUSTRALIA 105
    • 12.1.5 SOUTH KOREA 110
    • 12.1.6 NEW ZEALAND 115
    • 12.1.7 SINGAPORE 120
    • 12.1.8 THAILAND 125
    • 12.1.9 PHILIPPINES 130
    • 12.1.10 MALAYSIA 135
    • 12.1.11 INDONESIA 140
    • 12.1.12 VIETNAM 145
    • 12.1.13 TAIWAN 150
    • 12.1.14 REST OF ASIA-PACIFIC 155

13 ASIA-PACIFIC CHINESE HAMSTER OVARY (CHO) CELLS MARKET, COMPANY LANDSCAPE 156

  • 13.1 COMPANY SHARE ANALYSIS: ASIA-PACIFIC 156

14 SWOT ANALYSIS 157

15 COMPANY PROFILE 158

  • 15.1 SARTORIUS AG 158
    • 15.1.1 COMPANY SNAPSHOT 158
    • 15.1.2 REVENUE ANALYSIS 158
    • 15.1.3 PRODUCT PORTFOLIO 159
    • 15.1.4 RECENT DEVELOPMENT 159
  • 15.2 LONZA 160
    • 15.2.1 COMPANY SNAPSHOT 160
    • 15.2.2 REVENUE ANALYSIS 160
    • 15.2.3 PRODUCT PORTFOLIO 161
    • 15.2.4 RECENT DEVELOPMENT 161
  • 15.3 MERCK KGAA 162
    • 15.3.1 COMPANY SNAPSHOT 162
    • 15.3.2 REVENUE ANALYSIS 162
    • 15.3.3 PRODUCT PORTFOLIO 163
    • 15.3.4 RECENT DEVELOPMENT 163
  • 15.4 CYTIVA 164
    • 15.4.1 COMPANY SNAPSHOT 164
    • 15.4.2 PRODUCT PORTFOLIO 164
    • 15.4.3 RECENT DEVELOPMENT 164
  • 15.5 THERMO FISHER SCIENTIFIC INC. 165
    • 15.5.1 COMPANY SNAPSHOT 165
    • 15.5.2 REVENUE ANALYSIS 165
    • 15.5.3 PRODUCT PORTFOLIO 166
    • 15.5.4 RECENT DEVELOPMENT 166
  • 15.6 ABEOMICS 167
    • 15.6.1 COMPANY SNAPSHOT 167
    • 15.6.2 PRODUCT PORTFOLIO 167
    • 15.6.3 RECENT DEVELOPMENT 167
  • 15.7 ACCEGEN 168
    • 15.7.1 COMPANY SNAPSHOT 168
    • 15.7.2 PRODUCT PORTFOLIO 168
    • 15.7.3 RECENT DEVELOPMENT 168 
  • 15.8 APPLIED BIOLOGICAL MATERIALS INC. (ABM) 169
    • 15.8.1 COMPANY SNAPSHOT 169
    • 15.8.2 PRODUCT PORTFOLIO 169
    • 15.8.3 RECENT DEVELOPMENT 169
  • 15.9 ATCC 170
    • 15.9.1 COMPANY SNAPSHOT 170
    • 15.9.2 PRODUCT PORTFOLIO 170
    • 15.9.3 RECENT DEVELOPMENT 170
  • 15.10 BPS BIOSCIENCE, INC. 171
    • 15.10.1 COMPANY SNAPSHOT 171
    • 15.10.2 PRODUCT PORTFOLIO 171
    • 15.10.3 RECENT DEVELOPMENT 172
  • 15.11 CLS CELL LINES SERVICE GMBH 173
    • 15.11.1 COMPANY SNAPSHOT 173
    • 15.11.2 PRODUCT PORTFOLIO 173
    • 15.11.3 RECENT DEVELOPMENT 173
  • 15.12 CURIA GLOBAL, INC. 174
    • 15.12.1 COMPANY SNAPSHOT 174
    • 15.12.2 PRODUCT PORTFOLIO 174
    • 15.12.3 RECENT DEVELOPMENT 174
  • 15.13 GENTARGET INC. 175
    • 15.13.1 COMPANY SNAPSHOT 175
    • 15.13.2 PRODUCT PORTFOLIO 175
    • 15.13.3 RECENT DEVELOPMENT 175
  • 15.14 HORIZON DISCOVERY LTD. 176
    • 15.14.1 COMPANY SNAPSHOT 176
    • 15.14.2 PRODUCT PORTFOLIO 176
    • 15.14.3 RECENT DEVELOPMENT 176
  • 15.15 PROMEGA CORPORATION 177
    • 15.15.1 COMPANY SNAPSHOT 177
    • 15.15.2 PRODUCT PORTFOLIO 177
    • 15.15.3 RECENT DEVELOPMENT 177
  • 15.16 RAYBIOTECH LIFE, INC. 178
    • 15.16.1 COMPANY SNAPSHOT 178
    • 15.16.2 PRODUCT PORTFOLIO 178
    • 15.16.3 RECENT DEVELOPMENT 178

16 QUESTIONNAIRE 179

17 RELATED REPORTS 183

LIST OF TABLES

  • TABLE 1 ICH GUIDELINES FOR CHO CELL-BASED PRODUCTS 43
  • TABLE 2 ASIA-PACIFIC CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2022-2030 (USD THOUSAND) 61
  • TABLE 3 ASIA-PACIFIC PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 62
  • TABLE 4 ASIA-PACIFIC CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 63
  • TABLE 5 ASIA-PACIFIC CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY SYSTEM, 2021-2030 (USD THOUSAND) 67
  • TABLE 6 ASIA-PACIFIC CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 72
  • TABLE 7 ASIA-PACIFIC BIOLOGICS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 73
  • TABLE 8 ASIA-PACIFIC CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 78
  • TABLE 9 ASIA-PACIFIC BIOPHARMACEUTICAL COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 79
  • TABLE 10 ASIA-PACIFIC BIOTECHNOLOGY COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 79
  • TABLE 11 ASIA-PACIFIC CLINICAL DEVELOPMENT AND MANUFACTURING ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 80
  • TABLE 12 ASIA-PACIFIC CLINICAL RESEARCH ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 81
  • TABLE 13 ASIA-PACIFIC CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 85
  • TABLE 14 ASIA-PACIFIC CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY COUNTRY, 2021-2030 (USD THOUSAND) 89
  • TABLE 15 CHINA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 90
  • TABLE 16 CHINA PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 90
  • TABLE 17 CHINA PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 ASP 90
  • TABLE 18 CHINA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS) 91
  • TABLE 19 CHINA CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 91
  • TABLE 20 CHINA CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 ASP 91
  • TABLE 21 CHINA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS) 91
  • TABLE 22 CHINA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY SYSTEM, 2021-2030 (USD THOUSAND) 92
  • TABLE 23 CHINA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 92
  • TABLE 24 CHINA BIOLOGICS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 92
  • TABLE 25 CHINA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 93
  • TABLE 26 CHINA BIOPHARMACEUTICAL COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 93
  • TABLE 27 CHINA BIOTECHNOLOGY COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 93
  • TABLE 28 CHINA CLINICAL DEVELOPMENT AND MANUFACTURING ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 94
  • TABLE 29 CHINA CLINICAL RESEARCH ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 94
  • TABLE 30 CHINA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 94
  • TABLE 31 JAPAN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 95
  • TABLE 32 JAPAN PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 95
  • TABLE 33 JAPAN PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 ASP 95
  • TABLE 34 JAPAN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS) 96
  • TABLE 35 JAPAN CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 96
  • TABLE 36 JAPAN CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 ASP 96
  • TABLE 37 JAPAN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS) 96
  • TABLE 38 JAPAN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY SYSTEM, 2021-2030 (USD THOUSAND) 97
  • TABLE 39 JAPAN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 97
  • TABLE 40 JAPAN BIOLOGICS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 97
  • TABLE 41 JAPAN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 98
  • TABLE 42 JAPAN BIOPHARMACEUTICAL COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 98
  • TABLE 43 JAPAN BIOTECHNOLOGY COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 98
  • TABLE 44 JAPAN CLINICAL DEVELOPMENT AND MANUFACTURING ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 99
  • TABLE 45 JAPAN CLINICAL RESEARCH ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 99
  • TABLE 46 JAPAN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 99
  • TABLE 47 INDIA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 100
  • TABLE 48 INDIA PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 100
  • TABLE 49 INDIA PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 ASP 100
  • TABLE 50 INDIA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS) 101
  • TABLE 51 INDIA CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 101
  • TABLE 52 INDIA CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 ASP 101
  • TABLE 53 INDIA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS) 101
  • TABLE 54 INDIA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY SYSTEM, 2021-2030 (USD THOUSAND) 102
  • TABLE 55 INDIA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 102
  • TABLE 56 INDIA BIOLOGICS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 102
  • TABLE 57 INDIA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 103
  • TABLE 58 INDIA BIOPHARMACEUTICAL COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 103
  • TABLE 59 INDIA BIOTECHNOLOGY COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 103
  • TABLE 60 INDIA CLINICAL DEVELOPMENT AND MANUFACTURING ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 104
  • TABLE 61 INDIA CLINICAL RESEARCH ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 104
  • TABLE 62 INDIA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 104
  • TABLE 63 AUSTRALIA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 105
  • TABLE 64 AUSTRALIA PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 105
  • TABLE 65 AUSTRALIA PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 ASP 105
  • TABLE 66 AUSTRALIA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS) 106
  • TABLE 67 AUSTRALIA CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 106
  • TABLE 68 AUSTRALIA CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 ASP 106
  • TABLE 69 AUSTRALIA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS) 106
  • TABLE 70 AUSTRALIA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY SYSTEM, 2021-2030 (USD THOUSAND) 107
  • TABLE 71 AUSTRALIA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 107
  • TABLE 72 AUSTRALIA BIOLOGICS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 107
  • TABLE 73 AUSTRALIA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 108
  • TABLE 74 AUSTRALIA BIOPHARMACEUTICAL COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 108
  • TABLE 75 AUSTRALIA BIOTECHNOLOGY COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 108
  • TABLE 76 AUSTRALIA CLINICAL DEVELOPMENT AND MANUFACTURING ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 109
  • TABLE 77 AUSTRALIA CLINICAL RESEARCH ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 109
  • TABLE 78 AUSTRALIA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 109
  • TABLE 79 SOUTH KOREA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 110
  • TABLE 80 SOUTH KOREA PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 110
  • TABLE 81 SOUTH KOREA PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 ASP 110
  • TABLE 82 SOUTH KOREA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS) 111
  • TABLE 83 SOUTH KOREA CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 111
  • TABLE 84 SOUTH KOREA CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 ASP 111
  • TABLE 85 SOUTH KOREA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS) 111
  • TABLE 86 SOUTH KOREA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY SYSTEM, 2021-2030 (USD THOUSAND) 112
  • TABLE 87 SOUTH KOREA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 112
  • TABLE 88 SOUTH KOREA BIOLOGICS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 112
  • TABLE 89 SOUTH KOREA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 113
  • TABLE 90 SOUTH KOREA BIOPHARMACEUTICAL COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 113
  • TABLE 91 SOUTH KOREA BIOTECHNOLOGY COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 113
  • TABLE 92 SOUTH KOREA CLINICAL DEVELOPMENT AND MANUFACTURING ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 114
  • TABLE 93 SOUTH KOREA CLINICAL RESEARCH ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 114
  • TABLE 94 SOUTH KOREA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 114
  • TABLE 95 NEW ZEALAND CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 115
  • TABLE 96 NEW ZEALAND PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 115
  • TABLE 97 NEW ZEALAND PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 ASP 115
  • TABLE 98 NEW ZEALAND CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS) 116
  • TABLE 99 NEW ZEALAND CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 116
  • TABLE 100 NEW ZEALAND CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 ASP 116
  • TABLE 101 NEW ZEALAND CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS) 116
  • TABLE 102 NEW ZEALAND CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY SYSTEM, 2021-2030 (USD THOUSAND) 117
  • TABLE 103 NEW ZEALAND CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 117
  • TABLE 104 NEW ZEALAND BIOLOGICS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 117
  • TABLE 105 NEW ZEALAND CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 118
  • TABLE 106 NEW ZEALAND BIOPHARMACEUTICAL COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 118
  • TABLE 107 NEW ZEALAND BIOTECHNOLOGY COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 118
  • TABLE 108 NEW ZEALAND CLINICAL DEVELOPMENT AND MANUFACTURING ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 119
  • TABLE 109 NEW ZEALAND CLINICAL RESEARCH ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 119
  • TABLE 110 NEW ZEALAND CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 119
  • TABLE 111 SINGAPORE CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 120
  • TABLE 112 SINGAPORE PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 120
  • TABLE 113 SINGAPORE PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 ASP 120
  • TABLE 114 SINGAPORE CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS) 121
  • TABLE 115 SINGAPORE CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 121
  • TABLE 116 SINGAPORE CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 ASP 121
  • TABLE 117 SINGAPORE CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS) 121
  • TABLE 118 SINGAPORE CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY SYSTEM, 2021-2030 (USD THOUSAND) 122
  • TABLE 119 SINGAPORE CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 122
  • TABLE 120 SINGAPORE BIOLOGICS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 122
  • TABLE 121 SINGAPORE CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 123
  • TABLE 122 SINGAPORE BIOPHARMACEUTICAL COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 123
  • TABLE 123 SINGAPORE BIOTECHNOLOGY COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 123
  • TABLE 124 SINGAPORE CLINICAL DEVELOPMENT AND MANUFACTURING ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 124
  • TABLE 125 SINGAPORE CLINICAL RESEARCH ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 124
  • TABLE 126 SINGAPORE CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 124
  • TABLE 127 THAILAND CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 125
  • TABLE 128 THAILAND PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 125
  • TABLE 129 THAILAND PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 ASP 125
  • TABLE 130 THAILAND CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS) 126
  • TABLE 131 THAILAND CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 126
  • TABLE 132 THAILAND CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 ASP 126
  • TABLE 133 THAILAND CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS) 126
  • TABLE 134 THAILAND CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY SYSTEM, 2021-2030 (USD THOUSAND) 127
  • TABLE 135 THAILAND CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 127
  • TABLE 136 THAILAND BIOLOGICS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 127
  • TABLE 137 THAILAND CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 128
  • TABLE 138 THAILAND BIOPHARMACEUTICAL COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 128
  • TABLE 139 THAILAND BIOTECHNOLOGY COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 128
  • TABLE 140 THAILAND CLINICAL DEVELOPMENT AND MANUFACTURING ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 129
  • TABLE 141 THAILAND CLINICAL RESEARCH ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 129
  • TABLE 142 THAILAND CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 129
  • TABLE 143 PHILIPPINES CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 130
  • TABLE 144 PHILIPPINES PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 130
  • TABLE 145 PHILIPPINES PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 ASP 130
  • TABLE 146 PHILIPPINES CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS) 131
  • TABLE 147 PHILIPPINES CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 131
  • TABLE 148 PHILIPPINES CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 ASP 131
  • TABLE 149 PHILIPPINES CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS) 131
  • TABLE 150 PHILIPPINES CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY SYSTEM, 2021-2030 (USD THOUSAND) 132
  • TABLE 151 PHILIPPINES CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 132
  • TABLE 152 PHILIPPINES BIOLOGICS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 132
  • TABLE 153 PHILIPPINES CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 133
  • TABLE 154 PHILIPPINES BIOPHARMACEUTICAL COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 133
  • TABLE 155 PHILIPPINES BIOTECHNOLOGY COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 133
  • TABLE 156 PHILIPPINES CLINICAL DEVELOPMENT AND MANUFACTURING ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 134
  • TABLE 157 PHILIPPINES CLINICAL RESEARCH ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 134
  • TABLE 158 PHILIPPINES CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 134
  • TABLE 159 MALAYSIA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 135
  • TABLE 160 MALAYSIA PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 135
  • TABLE 161 MALAYSIA PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 ASP 135
  • TABLE 162 MALAYSIA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS) 136
  • TABLE 163 MALAYSIA CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 136
  • TABLE 164 MALAYSIA CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 ASP 136
  • TABLE 165 MALAYSIA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS) 136
  • TABLE 166 MALAYSIA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY SYSTEM, 2021-2030 (USD THOUSAND) 137
  • TABLE 167 MALAYSIA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 137
  • TABLE 168 MALAYSIA BIOLOGICS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 137
  • TABLE 169 MALAYSIA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 138
  • TABLE 170 MALAYSIA BIOPHARMACEUTICAL COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 138
  • TABLE 171 MALAYSIA BIOTECHNOLOGY COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 138
  • TABLE 172 MALAYSIA CLINICAL DEVELOPMENT AND MANUFACTURING ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 139
  • TABLE 173 MALAYSIA CLINICAL RESEARCH ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 139
  • TABLE 174 MALAYSIA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 139
  • TABLE 175 INDONESIA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 140
  • TABLE 176 INDONESIA PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 140
  • TABLE 177 INDONESIA PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 ASP 140
  • TABLE 178 INDONESIA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS) 141
  • TABLE 179 INDONESIA CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 141
  • TABLE 180 INDONESIA CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 ASP 141
  • TABLE 181 INDONESIA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS) 141
  • TABLE 182 INDONESIA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY SYSTEM, 2021-2030 (USD THOUSAND) 142
  • TABLE 183 INDONESIA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 142
  • TABLE 184 INDONESIA BIOLOGICS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 142
  • TABLE 185 INDONESIA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 143
  • TABLE 186 INDONESIA BIOPHARMACEUTICAL COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 143
  • TABLE 187 INDONESIA BIOTECHNOLOGY COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 143
  • TABLE 188 INDONESIA CLINICAL DEVELOPMENT AND MANUFACTURING ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 144
  • TABLE 189 INDONESIA CLINICAL RESEARCH ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 144
  • TABLE 190 INDONESIA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 144
  • TABLE 191 VIETNAM CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 145
  • TABLE 192 VIETNAM PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 145
  • TABLE 193 VIETNAM PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 ASP 145
  • TABLE 194 VIETNAM CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS) 146
  • TABLE 195 VIETNAM CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 146
  • TABLE 196 VIETNAM CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 ASP 146
  • TABLE 197 VIETNAM CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS) 146
  • TABLE 198 VIETNAM CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY SYSTEM, 2021-2030 (USD THOUSAND) 147
  • TABLE 199 VIETNAM CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 147
  • TABLE 200 VIETNAM BIOLOGICS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 147
  • TABLE 201 VIETNAM CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 148
  • TABLE 202 VIETNAM BIOPHARMACEUTICAL COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 148
  • TABLE 203 VIETNAM BIOTECHNOLOGY COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 148
  • TABLE 204 VIETNAM CLINICAL DEVELOPMENT AND MANUFACTURING ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 149
  • TABLE 205 VIETNAM CLINICAL RESEARCH ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 149
  • TABLE 206 VIETNAM CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 149
  • TABLE 207 TAIWAN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 150
  • TABLE 208 TAIWAN PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 150
  • TABLE 209 TAIWAN PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 ASP 150
  • TABLE 210 TAIWAN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS) 151
  • TABLE 211 TAIWAN CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 151
  • TABLE 212 TAIWAN CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 ASP 151
  • TABLE 213 TAIWAN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS) 151
  • TABLE 214 TAIWAN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY SYSTEM, 2021-2030 (USD THOUSAND) 152
  • TABLE 215 TAIWAN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 152
  • TABLE 216 TAIWAN BIOLOGICS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 152
  • TABLE 217 TAIWAN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 153
  • TABLE 218 TAIWAN BIOPHARMACEUTICAL COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 153
  • TABLE 219 TAIWAN BIOTECHNOLOGY COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 153
  • TABLE 220 TAIWAN CLINICAL DEVELOPMENT AND MANUFACTURING ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 154
  • TABLE 221 TAIWAN CLINICAL RESEARCH ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 154
  • TABLE 222 TAIWAN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 154
  • TABLE 223 REST OF ASIA-PACIFIC CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 155

LIST OF FIGURES

  • FIGURE 1 ASIA-PACIFIC CHINESE HAMSTER OVARY CELLS (CHO) MARKET: SEGMENTATION 26
  • FIGURE 2 ASIA-PACIFIC CHINESE HAMSTER OVARY CELLS (CHO) MARKET: DATA TRIANGULATION 28
  • FIGURE 3 ASIA-PACIFIC CHINESE HAMSTER OVARY CELLS (CHO) MARKET: DROC ANALYSIS 29
  • FIGURE 4 ASIA-PACIFIC CHINESE HAMSTER OVARY CELLS (CHO) MARKET: ASIA-PACIFIC VS REGIONAL MARKET ANALYSIS 30
  • FIGURE 5 ASIA-PACIFIC CHINESE HAMSTER OVARY CELLS (CHO) MARKET: COMPANY RESEARCH ANALYSIS 30
  • FIGURE 6 ASIA-PACIFIC CHINESE HAMSTER OVARY CELLS (CHO) MARKET: INTERVIEW DEMOGRAPHICS 32
  • FIGURE 7 ASIA-PACIFIC CHINESE HAMSTER OVARY CELLS (CHO) MARKET: DBMR MARKET POSITION GRID 33
  • FIGURE 8 ASIA-PACIFIC CHINESE HAMSTER OVARY CELLS (CHO) MARKET: MARKET APPLICATION COVERAGE GRID 34
  • FIGURE 9 ASIA-PACIFIC CHINESE HAMSTER OVARY CELLS (CHO) MARKET: VENDOR SHARE ANALYSIS 35
  • FIGURE 10 ASIA-PACIFIC CHINESE HAMSTER OVARY CELLS (CHO) MARKET: SEGMENTATION 39
  • FIGURE 11 GROWING DEMAND FOR BIOPHARMACEUTICALS IS EXPECTED TO DRIVE THE ASIA-PACIFIC CHINESE HAMSTER OVARY CELLS (CHO) MARKET GROWTH IN THE FORECAST PERIOD OF 2023 TO 2030 40
  • FIGURE 12 SERVICES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE ASIA-PACIFIC CHINESE HAMSTER OVARY CELLS (CHO) MARKET IN THE FORECAST PERIOD OF 2023 & 2030 40
  • FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE ASIA-PACIFIC CHINESE HAMSTER OVARY CELLS (CHO) MARKET 46
  • FIGURE 14 ASIA-PACIFIC CHINESE HAMSTER OVARY (CHO) CELLS MARKET: BY TYPE, 2022 59
  • FIGURE 15 ASIA-PACIFIC CHINESE HAMSTER OVARY (CHO) CELLS MARKET: BY TYPE, 2023-2030 (USD THOUSAND) 60
  • FIGURE 16 ASIA-PACIFIC CHINESE HAMSTER OVARY (CHO) CELLS MARKET: BY TYPE, CAGR (2023-2030) 60
  • FIGURE 17 ASIA-PACIFIC CHINESE HAMSTER OVARY (CHO) CELLS MARKET: BY TYPE, LIFELINE CURVE 61
  • FIGURE 18 ASIA-PACIFIC CHINESE HAMSTER OVARY (CHO) CELLS MARKET: BY SYSTEM, 2022 65
  • FIGURE 19 ASIA-PACIFIC CHINESE HAMSTER OVARY (CHO) CELLS MARKET: BY SYSTEM, 2023-2030 (USD THOUSAND) 66
  • FIGURE 20 ASIA-PACIFIC CHINESE HAMSTER OVARY (CHO) CELLS MARKET: BY SYSTEM, CAGR (2023-2030) 66
  • FIGURE 21 ASIA-PACIFIC CHINESE HAMSTER OVARY (CHO) CELLS MARKET: BY SYSTEM, LIFELINE CURVE 67
  • FIGURE 22 ASIA-PACIFIC CHINESE HAMSTER OVARY (CHO) CELLS MARKET: BY APPLICATION, 2022 70
  • FIGURE 23 ASIA-PACIFIC CHINESE HAMSTER OVARY (CHO) CELLS MARKET: BY APPLICATION, 2023-2030 (USD THOUSAND) 71
  • FIGURE 24 ASIA-PACIFIC CHINESE HAMSTER OVARY (CHO) CELLS MARKET: BY APPLICATION, CAGR (2023-2030) 71
  • FIGURE 25 ASIA-PACIFIC CHINESE HAMSTER OVARY (CHO) CELLS MARKET: BY APPLICATION, LIFELINE CURVE 72
  • FIGURE 26 ASIA-PACIFIC CHINESE HAMSTER OVARY (CHO) CELLS MARKET: BY END USER, 2022 76
  • FIGURE 27 ASIA-PACIFIC CHINESE HAMSTER OVARY (CHO) CELLS MARKET: BY END USER, 2023-2030 (USD THOUSAND) 77
  • FIGURE 28 ASIA-PACIFIC CHINESE HAMSTER OVARY (CHO) CELLS MARKET: BY END USER, CAGR (2023-2030) 77
  • FIGURE 29 ASIA-PACIFIC CHINESE HAMSTER OVARY (CHO) CELLS MARKET: BY END USER, LIFELINE CURVE 78
  • FIGURE 30 ASIA-PACIFIC CHINESE HAMSTER OVARY (CHO) CELLS MARKET: BY END USER, 2022 83
  • FIGURE 31 ASIA-PACIFIC CHINESE HAMSTER OVARY (CHO) CELLS MARKET: BY END USER, 2023-2030 (USD THOUSAND) 84
  • FIGURE 32 ASIA-PACIFIC CHINESE HAMSTER OVARY (CHO) CELLS MARKET: BY END USER, CAGR (2023-2030) 84
  • FIGURE 33 ASIA-PACIFIC CHINESE HAMSTER OVARY (CHO) CELLS MARKET: BY END USER, LIFELINE CURVE 85
  • FIGURE 34 ASIA-PACIFIC CHINESE HAMSTER OVARY (CHO) CELLS MARKET SNAPSHOT 88
  • FIGURE 35 ASIA-PACIFIC CHINESE HAMSTER OVARY (CHO) CELLS MARKET: COMPANY SHARE 2022 (%) 156
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!